Tuesday 16th March 2021 | translated by MIKE SMITH
The regional government’s Department of Public Health has issued an action protocol to health professionals in the Comunidad Valenciana, a document in which the possible adverse affects that may be caused by the AstraZeneca vaccine are described and the diagnostic tests to be carried out in the event of an incident are detailed.
To date, 67,118 people in the Comunidad Valenciana have been administered with the AstraZeneca vaccine since the beginning of the vaccination campaign. However, the regional government confirmed Monday that the use of this particular vaccine would be suspended after the Interterritorial Council on National Health decided to do so for all groups, pending an investigation.
People who have already received a dose of AstraZeneca and have questions, doubts, concerns, or any adverse symptoms that arise within 14 days of its administration can ring 900 300 555 or 112.
Ana Barceló, the regional minister for Health, has insisted that “these are precautionary measures, as there have been no worrying adverse reactions reported in the Comunidad Valenciana“.
In fact, all international scientific organizations agree that – for the moment. there is no proven cause-effect relationship between the AstraZeneca vaccine and the 11 cases of cerebral venous sinus thrombosis (CVST) that have been detected in Europe so far.
Press Release – Generalitat Valenciana